Shares of Calyxt (NASDAQ:CLXT) were unchanged in pre-market trading after the company reported Q1 results.
Earnings per share were down 47.83% year over year to ($0.34), which missed the estimate of ($0.32).
Revenue of $2,377,000 up by 1414.01% year over year, which missed the estimate of $4,060,000.
Earnings guidance hasn't been issued by the company for now.
Calyxt hasn't issued any revenue guidance for the time being.
How To Listen To The Conference Call
Date: May 07, 2020
Time: 09:05 AM ET
52-week high: $16.48
Company's 52-week low was at $2.40
Price action over last quarter: Up 5.02%
Calyxt Inc is an agricultural biotechnology company. It mainly engages in the development of food and agricultural business. The company develops and creates specialty food ingredients, such as oils and high fiber wheat, and food crops with desirable traits such as herbicide tolerance. It develops products such as reduced trans-fat soya oil, potato, gluten reduced wheat, and lower saturated fat canola oil. It generates all of its revenue from R&D contracts related to plant gene editing.
See more from Benzinga
- Recap: Albireo Pharma Q1 Earnings
- Recap: International Seaways Q1 Earnings
- Recap: Oaktree Specialty Lending Q2 Earnings
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.